Cell & Gene Therapy Innovation Speaker

BryanDeane.jpeg

Eric Halioua

President & Chief Executive Officer

Mr. Eric Halioua, MS, MBA, serves as President of the Board, Chief Executive Officer and President of PDC line Pharma SAS. Mr. Halioua was a Co-Founder of PROMETHERA Biosciences S.A./N.V. and also served as its Chief Executive Officer. Mr. Halioua co-founded two other biotechnology companies, Myosix and Murigenetics and was a Board Member of the French public biotechnology company Vivalis. He was Principal in the Healthcare and Life Sciences Practice of Arthur D. Little for 11 years. He is an expert in developing viable industrial capacity for innovative cell therapies.